These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 37471613)
41. Cell-Free Human Papillomavirus-DNA for Monitoring Treatment Response of Head and Neck Squamous Cell Carcinoma: Systematic Review and Meta-Analysis. Campo F; Zocchi J; Moretto S; Mazzola F; Petruzzi G; Donà MG; Benevolo M; Iocca O; De Virgilio A; Pichi B; Manciocco V; Pellini R Laryngoscope; 2022 Mar; 132(3):560-568. PubMed ID: 34236084 [TBL] [Abstract][Full Text] [Related]
42. Oropharyngeal squamous cell carcinoma and HPV. Systematic review on overall management. De Santis S; Spinosi MC; Cambi J; Bengala C; Boccuzzi S J Stomatol Oral Maxillofac Surg; 2017 Apr; 118(2):103-108. PubMed ID: 28345518 [TBL] [Abstract][Full Text] [Related]
43. TRAF3/CYLD mutations identify a distinct subset of human papillomavirus-associated head and neck squamous cell carcinoma. Hajek M; Sewell A; Kaech S; Burtness B; Yarbrough WG; Issaeva N Cancer; 2017 May; 123(10):1778-1790. PubMed ID: 28295222 [TBL] [Abstract][Full Text] [Related]
44. Detectable Postoperative Circulating Tumor Human Papillomavirus DNA and Association with Recurrence in Patients With HPV-Associated Oropharyngeal Squamous Cell Carcinoma. Routman DM; Kumar S; Chera BS; Jethwa KR; Van Abel KM; Frechette K; DeWees T; Golafshar M; Garcia JJ; Price DL; Kasperbauer JL; Patel SH; Neben-Wittich MA; Laack NL; Chintakuntlawar AV; Price KA; Liu MC; Foote RL; Moore EJ; Gupta GP; Ma DJ Int J Radiat Oncol Biol Phys; 2022 Jul; 113(3):530-538. PubMed ID: 35157995 [TBL] [Abstract][Full Text] [Related]
45. The role of human papillomavirus in squamous carcinoma of the head and neck. Li G; Sturgis EM Curr Oncol Rep; 2006 Mar; 8(2):130-9. PubMed ID: 16507223 [TBL] [Abstract][Full Text] [Related]
46. The New Face of Head and Neck Cancer: The HPV Epidemic. Lewis A; Kang R; Levine A; Maghami E Oncology (Williston Park); 2015 Sep; 29(9):616-26. PubMed ID: 26384796 [TBL] [Abstract][Full Text] [Related]
47. Diagnostic Delay in Human Papillomavirus Negative Oropharyngeal Squamous Cell Carcinoma. Karp EE; Yin LX; O'Byrne TJ; Lu LY; Routman DM; Lester SC; Neben Wittich MA; Ma DJ; Price KA; Chintakuntlawar AV; Tasche KK; Price DL; Moore EJ; Van Abel KM Laryngoscope; 2023 Jun; 133(6):1394-1401. PubMed ID: 35851669 [TBL] [Abstract][Full Text] [Related]
48. Individualized circulating tumor DNA monitoring in head and neck squamous cell carcinoma. Kogo R; Manako T; Iwaya T; Nishizuka S; Hiraki H; Sasaki Y; Idogawa M; Tokino T; Koide A; Komune N; Yasumatsu R; Nakagawa T Cancer Med; 2022 Nov; 11(21):3960-3968. PubMed ID: 35352507 [TBL] [Abstract][Full Text] [Related]
49. A proposal for risk-based and strategy-adapted de-escalation in human papillomavirus-positive oropharyngeal squamous cell carcinoma. Wotman MT; Miles BA; Bakst RL; Posner MR Cancer; 2021 Dec; 127(23):4330-4338. PubMed ID: 34379804 [No Abstract] [Full Text] [Related]
50. miRNAs in human papilloma virus associated oral and oropharyngeal squamous cell carcinomas. Salazar C; Calvopiña D; Punyadeera C Expert Rev Mol Diagn; 2014 Nov; 14(8):1033-40. PubMed ID: 25222489 [TBL] [Abstract][Full Text] [Related]
51. Salivary HPV DNA informs locoregional disease status in advanced HPV-associated oropharyngeal cancer. Hanna GJ; Lau CJ; Mahmood U; Supplee JG; Mogili AR; Haddad RI; Jänne PA; Paweletz CP Oral Oncol; 2019 Aug; 95():120-126. PubMed ID: 31345379 [TBL] [Abstract][Full Text] [Related]
52. Human papillomavirus-associated oropharynx cancer (HPV-OPC): treatment options. Chau NG; Rabinowits G; Haddad RI Curr Treat Options Oncol; 2014 Dec; 15(4):595-610. PubMed ID: 25240410 [TBL] [Abstract][Full Text] [Related]
53. Nonuniform Distribution of High-risk Human Papillomavirus in Squamous Cell Carcinomas of the Oropharynx: Rethinking the Anatomic Boundaries of Oral and Oropharyngeal Carcinoma From an Oncologic HPV Perspective. Gelwan E; Malm IJ; Khararjian A; Fakhry C; Bishop JA; Westra WH Am J Surg Pathol; 2017 Dec; 41(12):1722-1728. PubMed ID: 28877058 [TBL] [Abstract][Full Text] [Related]
54. The discordant biomarker dilemma: What are the diagnostic implications of oropharyngeal squamous cell carcinomas with discrepant p16 and HPV results? Guzmán-Arocho YD; Nishino M Cancer Cytopathol; 2022 Nov; 130(11):844-848. PubMed ID: 35713385 [No Abstract] [Full Text] [Related]
56. Surgical margin status and role of adjuvant therapy in human papillomavirus-positive oropharyngeal cancer. Park YM; Lim JY; Koh YW; Choi EC; Kim SH Head Neck; 2023 Sep; 45(9):2369-2376. PubMed ID: 37489048 [TBL] [Abstract][Full Text] [Related]
57. De-escalation treatment of human papillomavirus-positive oropharyngeal squamous cell carcinoma: an evidence-based review for the locally advanced disease. Stock GT; Bonadio RRCC; de Castro G Curr Opin Oncol; 2018 May; 30(3):146-151. PubMed ID: 29474271 [TBL] [Abstract][Full Text] [Related]
58. Human papillomavirus in oropharyngeal cancer: The changing face of a disease. Mallen-St Clair J; Alani M; Wang MB; Srivatsan ES Biochim Biophys Acta; 2016 Dec; 1866(2):141-150. PubMed ID: 27487173 [TBL] [Abstract][Full Text] [Related]
59. Special Issue about Head and Neck Cancers: HPV Positive Cancers. Economopoulou P; Kotsantis I; Psyrri A Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32403287 [TBL] [Abstract][Full Text] [Related]
60. A Mouse Model of Oropharyngeal Papillomavirus-Induced Neoplasia Using Novel Tools for Infection and Nasal Anesthesia. Bilger A; King RE; Schroeder JP; Piette JT; Hinshaw LA; Kurth AD; AlRamahi RW; Barthel MV; Ward-Shaw ET; Buehler D; Masters KS; Thibeault SL; Lambert PF Viruses; 2020 Apr; 12(4):. PubMed ID: 32316091 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]